Novartis AG (FRA:NOT) Short Interest


FRA:NOT Novartis AG FRA:NOT
83 GF Score
Price €131.52
GF Value €109.77
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Novartis AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:NOT vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Novartis AG's Short Interest falls into.


FRA:NOT
83GF Score
Novartis AG FRA:NOT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novartis AG (FRA:NOT) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of €131.52 is trading 19.8% above its estimated GF Value™ of €109.77. GuruFocus considers Novartis AG to be Modestly Overvalued.

Key valuation signals for FRA:NOT:

  • Short Interest:
  • GF Value™: €109.77 vs. price of €131.52 (19.8% above fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the FRA:NOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
83GF Score

Get the complete analysis for FRA:NOT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€131.52
Price
€109.77
GF Value